Clinical Trial Update: Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV) [Phase 1]

View source ↗

Summary

This document notes a Phase 1 safety study of the HemoModulator System for treating HIV, with the current status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: Energex Systems, Inc. | Conditions: HIV, HIV Infections | Phase 1 | Status: UNKNOWN